OTC Monograph Reform, User Fee Legislation Coming 'Any Day' – CHPA
This article was originally published in The Pink Sheet
Executive Summary
Imminent OTC monograph reform legislation signals an agreement between industry and FDA on details of a proposal, which also includes a potential user fee program. CHPA also is hopeful for legislation restoring direct OTC drug purchases with pre-tax savings accounts.
You may also be interested in...
It’s Complicated: Health Care Act Simplifies Buying OTCs With Pre-Tax Accounts
CHPA gives tempered support for White House-backed legislation to replace the Affordable Care Act because it would eliminate requirement that consumers can only use pre-tax savings accounts for OTCs if they have a prescription.
Direct OTC Purchases With Pre-Tax Accounts Swing On ACA Change, Not Repeal
Sens. Pat Roberts, R-KS, and Heidi Heitkamp, D-ND, and Reps. Lynn Jenkins, R-KS and Ron Kind, D-WI, once again introduce the Restoring Access to Medications Act, proposing amending rather than repealing ACA.
OTC Drug Industry Could Stand To Gain With 'Pragmatist' In White House
With the Trump administration ahead, CHPA's highest regulatory priorities include eliminating a requirement from the Obama era that consumers get a prescription in order to pay for OTC drugs with pre-tax savings accounts and improving the Nixon-era monograph program.